Corrigendum to Joint Healthcare Infection Society (HIS) and Infection Prevention Society (IPS) guidelines for the prevention and control of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 118 (2021) S1 - S39
1 Department of Clinical Microbiology, Hospital South West Jutland, Esbjerg, Denmark; Department of Regional Health Research IRS, University of Southern Denmark, Denmark; Healthcare Infection Society, London, UK.
2 Richard Wells Research Centre, University of West London, London, UK; Infection Prevention Society, Seafield, UK.
5 Healthcare Infection Society, London, UK; MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.
6 Healthcare Infection Society, London, UK; Department of Clinical Microbiology, The Royal College of Surgeons, Ireland; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
7 Infection Prevention Society, Seafield, UK; East Kent Hospitals University, NHS Foundation Trust, Canterbury, UK.
8 Healthcare-associated Infection and Antimicrobial Resistance, Public Health England, London, UK; Paediatric Infectious Diseases and Immunology, Evelina London Children's Hospital, London, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK.
9 Infection Prevention Society, Seafield, UK; University Hospital Southampton NHS Foundation Trust, UK.
10 Infection Prevention Society, Seafield, UK; Oxford University Hospitals NHS Foundation Trust, UK.
12 Healthcare Infection Society, London, UK; NHS England and NHS Improvement, London, UK.
13 Healthcare Infection Society, London, UK; Guy's and St Thomas' NHS Foundation Trust, UK.
14 Healthcare Infection Society, London, UK; Clinical Microbiology & Public Health Laboratory, Public Health England, Addenbrooke's Hospital, Cambridge, UK.
15 Lay Member, UK.
16 Lay Member, UK; MRSA Action UK, Preston, UK.
17 Healthcare Infection Society, London, UK; University College London Hospitals NHS Foundation Trust, UK. Electronic address: [email protected].